{"id":20498,"date":"2026-07-31T10:32:58","date_gmt":"2026-07-31T10:32:58","guid":{"rendered":"https:\/\/woncaeurope2026.org\/sessions\/intensive-interprofessional-approach-to-the-control-of-type-2-diabetes-in-a-chronically-decompensated-patient-with-multiple-complications\/"},"modified":"2026-07-31T10:32:58","modified_gmt":"2026-07-31T10:32:58","slug":"intensive-interprofessional-approach-to-the-control-of-type-2-diabetes-in-a-chronically-decompensated-patient-with-multiple-complications","status":"publish","type":"wsa_session","link":"https:\/\/woncaeurope2026.org\/fr\/sessions\/intensive-interprofessional-approach-to-the-control-of-type-2-diabetes-in-a-chronically-decompensated-patient-with-multiple-complications\/","title":{"rendered":"Intensive interprofessional approach to the control of type 2 diabetes in a chronically decompensated patient with multiple complications"},"content":{"rendered":"<p>The care of individuals with type 2 diabetes (DM2) requires an interprofessional approach to ensure correct prescription, disease understanding, adequate nutrition, adherence to treatments, and reduction of complications. DM2 treatment should be intensive during periods of disease decompensation, aiming to improve glycemic control, primary or secondary prevention of cardiovascular outcomes, and reduction of target organ damage.We present the case report of a 78-year-old woman, hypertensive, obese, diabetic for over 30 years, with polyneuropathy and macro and microvascular complications (ischemic heart disease, proliferative diabetic retinopathy, and microalbuminuria). A review of medical records was conducted with data from 2016 to 2025. From 2016 to 2022, she had 7 medical consultations. Progressively higher glycated hemoglobin (HbA1c) levels were observed. It was used sulfonylureas, biguanides, and basal insulin. The patient suffered a myocardial infarction in 2022. She was received by an interprofessional primary health care (PHC) team and her care was coordinated by a family physician in August 2024. Hyperbasalization was identified, with a ratio of 8.2 IU of basal insulin to 1 IU of rapid-acting insulin, with an HbA1c of 13.6% (July 2024).This case report exemplifies how therapeutic inertia, sporadic uniprofessional care, hyperbasalization, and inappropriate use of antidiabetic drugs can lead to adverse outcomes.Over 14 months, 12 medical consultations were conducted, five with a nutritionist, three with a pharmacist, and two with a nurse. The ratio was adjusted to 1.25 IU of basal insulin for every 1 IU of rapid-acting insulin, with a final dose of 1.8 IU\/kg\/day of insulin. Dapagliflozin 10 mg once-daily was introduced. Finally, in September 2025, HbA1c reached 7.0% without episodes of hypoglycemia.The perception of hyperbasalization without achieving glycemic control and the intensification of interprofessional care concomitant with the optimization of pharmacotherapy enabled glycemic stabilization, with HbA1c at the therapeutic target, delaying the progression of macro and microvascular complications.This real clinical case demonstrates that even in complex situations, with clinical fragility and vulnerability, intensive and interprofessional care is capable of promoting glycemic control and improving quality of life.<\/p>\n","protected":false},"template":"","class_list":["post-20498","wsa_session","type-wsa_session","status-publish","hentry","description-off"],"_links":{"self":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/wsa_session\/20498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/wsa_session"}],"about":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/types\/wsa_session"}],"wp:attachment":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/media?parent=20498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}